[1]
H. M. Al-Temimi, K. j.Al-Shamma, and S. M.Alrubaie, “Evaluation of Metformin + Sitagliptin versus Metformin + Glibenclamide on Glycemic Control in Iraqis Type 2 Diabetic Patients”, Iraqi Journal of Pharmaceutical Sciences , vol. 21, no. 2, pp. 69–76, Mar. 2017, doi: 10.31351/vol21iss2pp69-76.